Type to search

Samsung Biologics Reaches Aagreement with Biogen to Acquire Full Ownership of Samsung Bioepis | Pharmtech Focus
FDA Approval of Aducanumab | Pharmtech Focus
Biogen and Bio-Thera Solutions Announce Commercialization and License Agreement for Proposed Biosimilar Currently in Phase 3 With the Potential to Treat Moderate to Severe Rheumatoid Arthritis | Pharmtech Focus